Biopharmaceutical Organization Selects Provantis® Pathology to Optimize Histopathology Reviews
Massachusetts Based Biopharmaceutical Company Automates Histopathology Processes
CONSHOHOCKEN, PA – June 9, 2016 - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that a US-based biopharmaceutical company has purchased Provantis® Pathology to provide storage for tissue imaging samples, along with analysis, review and reporting of histopathology data.
The client specializes in the development of a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Their investment in Provantis Pathology will enable them to further streamline the Histopathology review process, eliminating the use of high maintenance spreadsheets for data management and tracking.
- Biopharma client to implement Provantis Pathology to support histopathology processes
- Client will be able to produce tabulated study-based data, while referencing an integrated decision tree for sophisticated statistical analysis and reporting
- Tailored implementation and training plan deployed to ensure maximum return on investment
Gary Mitchell, Vice President of Marketing at Instem, said, “We are delighted to welcome this latest client to our user community. They represent a growing number of small teams that are gaining immediate value in their data collection, processing and reporting activities by implementing Provantis.”
Provantis Pathology is a fully integrated and scalable software solution used by organizations around the globe, helping single user remote Pathologists or global, multi-site customers collect, process and report gross and histopathology data faster and more accuractely. A comprehensive and intuitive system, Provantis Pathology is in use by leading research and development organizations across the life sciences spectrum.
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 450 clients through full service offices in the United States, United Kingdom Japan, India and China.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600